A hub for scientific capabilities and shared company value’s: BDD.
In this episode of Life and Life Science, Stephen Gannon speaks to Calum Stevens of BDD pharmaceutical. Calum explains the beneficial division of the business between innovation formulation and clinical development.
BDD Swift clinic accelerates the speed from drug formulation to market, while BDD innovation has amounted to the creation of unrivalled time-release technology. This ‘tab-in-tab’ development can specify medication release times within the body to incredibly tight time profiles. Calum also discusses hopes for the future of BDD, including a Good Manufacturing Practise (GMP) facility.
Check out the video here:
Want to see more? Check out our next episode with Paul Williamson at Realia Marketing.